Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Jan;58(1):104-6.
doi: 10.1136/jcp.2003.015537.

Langerhans cell histiocytosis in sequential discordant lymphoma

Affiliations
Case Reports

Langerhans cell histiocytosis in sequential discordant lymphoma

K Adu-Poku et al. J Clin Pathol. 2005 Jan.

Abstract

B cell non-Hodgkin lymphoma of the follicular subtype (grade 3/3) affecting the nasopharynx and breast, and containing foci of Langerhans cell histiocytosis, was diagnosed in a 56 year old white woman who was a longstanding heavy smoker. Four years before this she had developed stage 1a mixed cellularity Hodgkin lymphoma affecting the right inguinal region, which was treated by irradiation and chemotherapy without recurrence. Review of the original Hodgkin lymphoma histology demonstrated a small focus of Langerhans cell histiocytosis. This is thought to be the first recorded case of Langerhans cell histiocytosis occurring in a sequential discordant lymphoma. Its importance is discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Hodgkin lymphoma. (A) Reed-Sternberg and Hodgkin cells positive for (B) CD15 and (C) CD30 immunostaining. (D, E) Nodule of Langerhans cells with eosinophils showing central necrosis (haematoxylin and eosin stain). (F) Langerhans cells with strong CD1a expression.
Figure 2
Figure 2
The nasopharyngeal B cell non-Hodgkin lymphoma. (A) CD20 expression and (B) nodules of Langerhans cell histiocytosis (C) with strong CD1a positivity.

References

    1. Birbeck MS, Breathnach AJ, Everall JD. An electron microscopic study of basal melanocytes and high level clear cells (Langerhan’s cells) in vitiligo. J Invest Dermatol 1961;37:51–64.
    1. Nezelof C , Basset F, Rousseau MF. Histiocytosis X: histiogentetic arguments for Langerhans cell origin. Biomedicine 1973;18:365–71. - PubMed
    1. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983;14:847–56. - PubMed
    1. D’Aglio GJ, Favora BE, Ladish S. Workshop on the childhood histiocytosis X: concepts and controversies. Med Pediatr Oncol 1986;14:104–17.
    1. Osband ME, Lipton JM, Lavin P, et al. Histiocytosis X: demonstration of abnormal immunity. N Engl J Med 1981;304:146–53. - PubMed

Publication types

MeSH terms